Priority of experimental evidence.
Nishizawa
Shigeru
S
D000818:Animals; D001488:Basilar Artery / Q000201:enzymology / Q000503:physiopathology; D004195:Disease Models, Animal; D018450:Disease Progression; D004285:Dogs; D047908:Intracellular Signaling Peptides and Proteins; D007527:Isoenzymes / Q000378:metabolism; D011493:Protein Kinase C / Q000378:metabolism*; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism; D011817:Rabbits; D012107:Research Design; D015398:Signal Transduction; D013345:Subarachnoid Hemorrhage / Q000150:complications / Q000201:enzymology / Q000503:physiopathology*; D020301:Vasospasm, Intracranial / Q000209:etiology / Q000503:physiopathology*; D054460:rho-Associated Kinases
D047908:Intracellular Signaling Peptides and Proteins; D007527:Isoenzymes; D017346:Protein Serine-Threonine Kinases; D054460:rho-Associated Kinases; D011493:Protein Kinase C